RE:RE:Private Placement 8 insiders.....
REPLICEL LIFE SCIENCES INC. ("RP")
BULLETIN TYPE: Private Placement-Non-Brokered
BULLETIN DATE: January 4, 2023
TSX Venture Tier 1 Company
TSX Venture Exchange has accepted for filing documentation with respect to a Non-Brokered Private Placement announced on September 6, 2022:
| Number of Shares: | 8,419,650 shares |
| | |
| Purchase Price: | $0.10 per share |
| | |
| Warrants: | 4,209,825 share purchase warrants to purchase 4,209,825 shares |
| | |
| Warrant Exercise Price: | $0.20 for a three year period |
| | |
| Number of Placees: | 8 placees |
| Insider / Pro Group Participation: | | |
| | | |
| Placees | # of Placee (s) | Aggregate # of Shares |
| | | |
| Aggregate Existing Insider Involvement: | 8 | 7,869,650 |
| Aggregate Pro Group Involvement: | N/A | N/A |
| | Aggregate Cash Amount | Aggregate # of Shares | Aggregate # of Warrants |
| Finder's Fee: | N/A | N/A | N/A |
The Company issued a news release on January 3, 2023 confirming closing of the private placement. [Note that in certain circumstances the Exchange may later extend the expiry date of the warrants, if they are less than the maximum permitted term.]